2X7.F Stock Analysis
2X
Uncovered
OrthoPediatrics Corp is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 203 full-time employees. The company went IPO on 2017-10-12. The firm is primarily engaged in designing, developing and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The firm operates through the OrthoPediatrics Segment, which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. The firm offers a range of products, such as PediLoc , PediPlates , Cannulated Screws, PediFlex nail, PediNail , PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, ApiFix Mid-C System and Mitchell Ponseti specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets.